Idiopathic pulmonary fibrosis (IPF) is a type of chronic lung disease characterized by a progressive and irreversible decline in lung function. 

Aragen Bioscience has a portfolio of in vivo fibrosis models, we offer customised and high quality animal models with ex vivo readouts to support our clients anti-fibrosis drug development.

Download our whitepaper which highlights three case studies:

  1. Differential Analysis of Infiltrating Leukocytes from BAL Harvest plus Changes in Histology
  2. Changes in Lung Function in Bleomycin-Induced IPF
  3. Efficacy of a Small Molecule Compound in Bleomycin-Induced IPF
A Highly Reproducible In Vivo Model for Bleomycin-Induced 
Lung Fibrosis in Mice to Evaluate Drugs for the Treatment of Idiopathic Pulmonary Fibrosis

© 2019 GVK Biosciences Private Limited. All Rights Reserved
Terms & Conditions | Privacy Policy | Privacy Notice - Customers/Vendors/Job Applicants

Please complete the form to download